Travere Therapeutics (TVTX) Change in Taxes (2015 - 2022)
Travere Therapeutics (TVTX) reported Change in Taxes of -$22000.0 for Q4 2022, up 76.34% on a YoY basis from -$12475.6 in Q4 2021, and down 108.33% quarter-over-quarter from $264000.0 in Q3 2022.
Travere Therapeutics (TVTX) Change in Taxes (2015 - 2022) Analysis & Trends
Travere Therapeutics has reported Change in Taxes for 7 years, with the latest figure at -$22000.0 in Q4 2022.
- For the quarter ending Q4 2022, Change in Taxes rose 76.34% year-over-year to -$22000.0; the trailing twelve-month figure through Dec 2022 stood at $154000.0 (up 100.9% YoY), and the FY2025 full-year result was -$849000.0, down 2170.73% from the prior year.
- Change in Taxes for Q4 2022 stood at -$22000.0, down from $264000.0 in the prior quarter.
- The five-year high for Change in Taxes was $18.8 million in Q1 2020, with the low at -$16.8 million in Q2 2021.
- Historically, Change in Taxes has averaged -$128153.8 across 4 years, with a median of -$74000.0 in 2020.
- Annual changes were most pronounced in 2020 — Change in Taxes jumped 6280.26% — and 2021, when it sank 22566.22%.
- Travere Therapeutics' Change in Taxes stood at -$555000.0 in 2019, then jumped by 735.32% to $3.5 million in 2020, then tumbled by 102.64% to -$93000.0 in 2021, then soared by 76.34% to -$22000.0 in 2022.
- The last three Change in Taxes figures came in at -$22000.0 (Q4 2022), $264000.0 (Q3 2022), and -$93000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Travere Therapeutics | 5.07 Bn | 4.99 Bn | 102.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -22,000.00 |
| Dec 31, 2022 | -22,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Sep 30, 2022 | 264,000.00 |
| Dec 31, 2021 | -93,000.00 |
| Dec 31, 2021 | -93,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Sep 30, 2021 | 5,000.00 |
| Jun 30, 2021 | -16.77 Mn |
| Jun 30, 2021 | -16.77 Mn |
| Mar 31, 2021 | -238,000.00 |
| Mar 31, 2021 | -238,000.00 |
| Dec 31, 2020 | 3.53 Mn |
| Dec 31, 2020 | 3.53 Mn |
| Sep 30, 2020 | -6.49 Mn |
| Sep 30, 2020 | -6.49 Mn |
| Jun 30, 2020 | -74,000.00 |
| Jun 30, 2020 | -74,000.00 |
| Mar 31, 2020 | 18.79 Mn |
| Mar 31, 2020 | 18.79 Mn |